ReviewCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2001
Variant Creutzfeldt-Jakob disease: a summary of current scientific knowledge in relation to public health.
Review in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Notification and support for people exposed to the risk of Creutzfeldt-Jakob disease (CJD) (or other prion diseases) through medical treatment (iatrogenically).The Cochrane database of systematic reviews · 2011Pooled it
- Preoperative autologous blood donation reduces the need for allogeneic blood products: a prospective randomized study.Canadian journal of surgery. Journal canadien de chirurgie · 2008Trial
- Creutzfeldt-Jakob disease mortality in Canada, 1998 to 2013.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2015Article
- Nanopore analysis of wild-type and mutant prion protein (PrP(C)): single molecule discrimination and PrP(C) kinetics.PloS one · 2013Article
- Evidence for prion-like mechanisms in several neurodegenerative diseases: potential implications for immunotherapy.Clinical & developmental immunology · 2013Review
- Detection and control of prion diseases in food animals.ISRN veterinary science · 2012Article
- Wild game feasts and fatal degenerative neurologic illness.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2003Article
- Cell mediated immune responses against human prion protein.Clinical and experimental immunology · 2003Article
- Creutzfeldt-Jakob disease and infection control.The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses · 2001Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prion diseases pose unique scientific, medical, veterinary and regulatory challenges. Here, we summarize current information bearing on the natural history, pathobiology and epidemiology of these disorders and public policy responses to the potential threats to public health posed, particularly, by bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease (vCJD). Six years after the first case reports of vCJD, there is still no clear indication of the magnitude of the primary epidemic, or of the likelihood of lateral transmission of this untreatable disease by iatrogenic means, particularly by blood and blood products. However, the unsettling nature of the available evidence warrants prudence regarding public health policy and regulation, as well as a forward-looking approach to research.
Indexed as
Identifiers
11468957PMC81246What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.